CVRx, Inc. (CVRX)Healthcare | Medical Devices | Minneapolis, United States | NasdaqGS
1.39 USD
+0.05
(3.731%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 5:19 a.m. EDT
The investment case for CVRx is currently broken by a perfect storm of deteriorating fundamentals and aggressive short-term selling. The company is burning cash at an alarming rate, with operating cash flow and free cash flow both deeply negative, while simultaneously cutting guidance despite reporting top-line growth. This disconnect between revenue expansion and cash destruction is a classic value trap signal. The balance sheet is fragile, with debt nearly matching cash reserves and negative returns on equity and assets. While the stock trades at a low multiple relative to sales, the market has correctly priced in the inability to generate sustainable profits or cash flow. Technically, the stock is in a severe downtrend, having lost significant value over the last year and trading well below its moving averages. The recent price action shows continued weakness, with the stock struggling to find support. The statistical forecasting model predicts a slight further decline over the next 45 days, though its reliability is low due to the volatile nature of the price action. Options activity confirms the pessimistic sentiment, with traders positioning heavily for downside protection via puts while avoiding any bullish exposure. There is no speculative capital flowing in to support a recovery. Given the cash burn, the guidance cuts, and the lack of a clear path to profitability, the long-term outlook remains bleak. The stock lacks the fundamental moat or financial strength required for a turnaround story at this stage. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.210339 |
| AutoETS | 0.210340 |
| AutoTheta | 0.211556 |
| MSTL | 0.235032 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 18% |
| H-stat | 23.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.013 |
| Excess Kurtosis | -0.69 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 297.649 |
| Revenue per Share | 2.325 |
| Market Cap | 37,031,820 |
| Forward P/E | -0.74 |
| Beta | 0.77 |
| Profit Margins | -84.93% |
| Website | https://www.barostim.com |
As of Oct. 10, 2026, 5:19 a.m. EDT: Speculators are overwhelmingly bearish, evidenced by massive put volume and open interest compared to negligible call activity. Implied volatility for puts is significantly elevated relative to calls, indicating a fear of further downside. The lack of any in-the-money call positioning suggests the market sees the current price as a ceiling rather than a floor.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8603015 |
| Address1 | 9,201 West Broadway Avenue |
| Address2 | Suite 650 |
| All Time High | 33.135 |
| All Time Low | 1.28 |
| Ask | 1.39 |
| Ask Size | 2 |
| Audit Risk | 4 |
| Average Daily Volume10 Day | 620,160 |
| Average Daily Volume3 Month | 941,375 |
| Average Volume | 941,375 |
| Average Volume10Days | 620,160 |
| Beta | 0.767 |
| Bid | 1.36 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 0.749 |
| City | Minneapolis |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.39 |
| Current Ratio | 8.045 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.44 |
| Day Low | 1.332 |
| Debt To Equity | 297.649 |
| Display Name | CVRx |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,048,200 |
| Earnings Call Timestamp Start | 1,786,048,200 |
| Earnings Timestamp | 1,786,046,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -47,843,000 |
| Ebitda Margins | -0.78190005 |
| Enterprise To Ebitda | -0.665 |
| Enterprise To Revenue | 0.52 |
| Enterprise Value | 31,835,820 |
| Eps Current Year | -2.0171 |
| Eps Forward | -1.87748 |
| Eps Trailing Twelve Months | -1.97 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 763 416 2841 |
| Fifty Day Average | 2.6212 |
| Fifty Day Average Change | -1.2312001 |
| Fifty Day Average Change Percent | -0.46970856 |
| Fifty Two Week Change Percent | -86.03015 |
| Fifty Two Week High | 11.3 |
| Fifty Two Week High Change | -9.91 |
| Fifty Two Week High Change Percent | -0.8769911 |
| Fifty Two Week Low | 1.28 |
| Fifty Two Week Low Change | 0.110000014 |
| Fifty Two Week Low Change Percent | 0.085937515 |
| Fifty Two Week Range | 1.28 - 11.3 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,625,059,800,000 |
| Float Shares | 18,308,638 |
| Forward Eps | -1.87748 |
| Forward P E | -0.74035406 |
| Free Cashflow | -23,801,750 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 223 |
| Fullday Change | 0.03999996 |
| Fullday Change Percent | 2.9850717 |
| Fullday Price | 1.39 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.86917 |
| Gross Profits | 53,183,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10335 |
| Held Percent Institutions | 0.66006 |
| Implied Shares Outstanding | 26,641,597 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-06-30 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. |
| Long Name | CVRx, Inc. |
| Market | us_market |
| Market Cap | 37,031,820 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1380491 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -51,968,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 72,465,143 |
| Number Of Analyst Opinions | 6 |
| Open | 1.36 |
| Operating Cashflow | -40,457,000 |
| Operating Margins | -0.82922995 |
| Overall Risk | 9 |
| Phone | 763 416 2840 |
| Previous Close | 1.34 |
| Price Eps Current Year | -0.6891081 |
| Price Hint | 4 |
| Price To Book | 1.8558077 |
| Price To Sales Trailing12 Months | 0.60521376 |
| Profit Margins | -0.84932 |
| Quick Ratio | 6.651 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.05 |
| Regular Market Change Percent | 3.73134 |
| Regular Market Day High | 1.44 |
| Regular Market Day Low | 1.332 |
| Regular Market Day Range | 1.332 - 1.44 |
| Regular Market Open | 1.36 |
| Regular Market Previous Close | 1.34 |
| Regular Market Price | 1.39 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 360,491 |
| Return On Assets | -0.28698 |
| Return On Equity | -1.3344501 |
| Revenue Growth | 0.156 |
| Revenue Per Share | 2.325 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 26,641,597 |
| Shares Percent Shares Out | 0.0744 |
| Shares Short | 1,982,426 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,968,589 |
| Short Name | CVRx, Inc. |
| Short Percent Of Float | 0.1042 |
| Short Ratio | 2.68 |
| Source Interval | 15 |
| State | MN |
| Symbol | CVRX |
| Target High Price | 6.0 |
| Target Low Price | 3.5 |
| Target Mean Price | 4.58333 |
| Target Median Price | 4.5 |
| Total Cash | 64,586,000 |
| Total Cash Per Share | 2.424 |
| Total Debt | 59,390,000 |
| Total Revenue | 61,188,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.97 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.6135 |
| Two Hundred Day Average Change | -4.2235003 |
| Two Hundred Day Average Change Percent | -0.7523827 |
| Type Disp | Equity |
| Volume | 360,491 |
| Website | https://www.barostim.com |
| Zip | 55,445 |